BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16602195)

  • 1. Acute neuropathic joint disease: a medical emergency?
    Jeffcoate WJ; Game FL; Armstrong DG; Cavanagh PR
    Diabetes Care; 2006 Apr; 29(4):951-2; author reply 952. PubMed ID: 16602195
    [No Abstract]   [Full Text] [Related]  

  • 2. Interaction between IGF-1, inflammation, and neuropathy in the pathogenesis of acute charcot neuroarthropathy: lessons from alendronate therapy and future perspectives of medical therapy.
    Pitocco D; Collina MC; Musella T; Ruotolo V; Caputo S; Manto A; Caradonna P; Galli M; Mancini L; Ghirlanda G
    Horm Metab Res; 2008 Mar; 40(3):163-4. PubMed ID: 18256973
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute Charcot arthropathy successfully treated with pamidronate: long-term follow-up.
    Naqvi A; Cuchacovich R; Saketkoo L; Espinoza LR
    Am J Med Sci; 2008 Feb; 335(2):145-8. PubMed ID: 18277124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of bone metabolism and developments in medical treatment of the diabetic Charcot foot.
    Jansen RB; Svendsen OL
    J Diabetes Complications; 2018 Jul; 32(7):708-712. PubMed ID: 29857955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes and acute Charcot neuroarthropathy--a call for heightened vigilance.
    Iheonunekwu N; Ibrahim TM; Ojuro I
    Niger J Med; 2010; 19(2):239-40. PubMed ID: 20642098
    [No Abstract]   [Full Text] [Related]  

  • 6. Six-month treatment with alendronate in acute Charcot neuroarthropathy: a randomized controlled trial.
    Pitocco D; Ruotolo V; Caputo S; Mancini L; Collina CM; Manto A; Caradonna P; Ghirlanda G
    Diabetes Care; 2005 May; 28(5):1214-5. PubMed ID: 15855594
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute neuropathic joint disease: a medical emergency?
    Tan AL; Greenstein A; Jarrett SJ; McGonagle D
    Diabetes Care; 2005 Dec; 28(12):2962-4. PubMed ID: 16306562
    [No Abstract]   [Full Text] [Related]  

  • 8. Medical treatment of Charcot neuroosteoarthropathy.
    Jostel A; Jude EB
    Clin Podiatr Med Surg; 2008 Jan; 25(1):63-9, vi-vii. PubMed ID: 18165112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diabetic Charcot foot.
    Dissanayake SU; Bowling FL; Jude EB
    Curr Diabetes Rev; 2012 May; 8(3):191-4. PubMed ID: 22429012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of acute Charcot foot with bisphosphonates: a systematic review of the literature.
    Richard JL; Almasri M; Schuldiner S
    Diabetologia; 2012 May; 55(5):1258-64. PubMed ID: 22361982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonates: a new treatment for diabetic Charcot neuroarthropathy?
    Selby PL; Young MJ; Boulton AJ
    Diabet Med; 1994; 11(1):28-31. PubMed ID: 8181248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of immobilization, off-loading and zoledronic acid on bone mineral density in patients with acute Charcot neuroarthropathy: a prospective randomized trial.
    Pakarinen TK; Laine HJ; Mäenpää H; Kähönen M; Mattila P; Lahtela J
    Foot Ankle Surg; 2013 Jun; 19(2):121-4. PubMed ID: 23548455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of zoledronic acid on the clinical resolution of Charcot neuroarthropathy: a pilot randomized controlled trial.
    Pakarinen TK; Laine HJ; Mäenpää H; Mattila P; Lahtela J
    Diabetes Care; 2011 Jul; 34(7):1514-6. PubMed ID: 21593295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial.
    Jude EB; Selby PL; Burgess J; Lilleystone P; Mawer EB; Page SR; Donohoe M; Foster AV; Edmonds ME; Boulton AJ
    Diabetologia; 2001 Nov; 44(11):2032-7. PubMed ID: 11719835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical image. A sequel of deranged metabolic control. Diabetes mellitus.
    Kumar N; Cheung YC; Varughese GI; Benn JJ; Willis AC
    N Z Med J; 2008 Jan; 121(1268):U2900. PubMed ID: 18256715
    [No Abstract]   [Full Text] [Related]  

  • 16. Alternative use of bisphosphonate therapy for rheumatic disease.
    Le Goff B; Berthelot JM; Maugars Y; Romas E
    Curr Pharm Des; 2010; 16(27):3045-52. PubMed ID: 20722620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonates for the treatment of Charcot neuroarthropathy.
    Anderson JJ; Woelffer KE; Holtzman JJ; Jacobs AM
    J Foot Ankle Surg; 2004; 43(5):285-9. PubMed ID: 15480402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healing of Charcot's joint by pamidronate infusion.
    Guis S; Pellissier JF; Arniaud D; Turck F; Witjas T; Roux H; Mattei JP
    J Rheumatol; 1999 Aug; 26(8):1843-5. PubMed ID: 10451089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosing osteomyelitis in patients with diabetic neuropathic osteoarthropathy.
    Devendra D; Farmer K; Bruce G; Hughes P; Vivian G; Millward BA
    Diabetes Care; 2001 Dec; 24(12):2154-5. PubMed ID: 11723101
    [No Abstract]   [Full Text] [Related]  

  • 20. A Surgeon's guide to advances in the pharmacological management of acute Charcot neuroarthropathy.
    Al-Nammari SS; Timothy T; Afsie S
    Foot Ankle Surg; 2013 Dec; 19(4):212-7. PubMed ID: 24095226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.